Toxicology of nanoparticles: A historical perspective

Nanotoxicology

Volumn 1, Issue 1, 2007, Pages 2-25

  Oberdörster, Günter ^a,d   Stone, Vicki ^b   Donaldson, Ken ^c  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b EDINBURGH NAPIER UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Fullerene; Human and environmental health; Nanoparticle; Nanotoxicology; Oxidative stress

Indexed keywords

ASBESTOS; CARBON; CARBON NANOTUBE; CYTOKINE; FULLERENE DERIVATIVE; GOLD; IRIDIUM; NANOPARTICLE; POLYSTYRENE; RADIOISOTOPE; SILICON DIOXIDE; TITANIUM DIOXIDE;

APOPTOSIS; CELL DEATH; CELLULAR DISTRIBUTION; CYTOKINE PRODUCTION; ECOTOXICOLOGY; ENVIRONMENT; ENVIRONMENTAL IMPACT; FUME; GENOTOXICITY; HEALTH HAZARD; HUMAN; IMMUNOGENICITY; INFLAMMATION; LIPID PEROXIDATION; NANOCHEMISTRY; NANOTECHNOLOGY; NONHUMAN; NOSE BREATHING; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PARTICLE SIZE; PHAGOCYTOSIS; PRIORITY JOURNAL; RADIATION PROTECTION; RESPIRATORY SYSTEM; REVIEW; RISK FACTOR; TOXICITY TESTING; TRANSCYTOSIS; VIROLOGY; WASTE DISPOSAL;

MAMMALIA;

EID: 34147106483     PISSN: 17435390     EISSN: 17435404     Source Type: Journal    
DOI: 10.1080/17435390701314761     Document Type: Review

References (176)

1. Adams RJ, Bray D. 1983. Rapid transport of foreign particles microinjected into crab axons. Nature 303:718-720.
2. Amdur MO, McCarthy JF, Gill MW. 1982. Respiratory response of Guinea pigs to zinc oxide fume. Am Ind Hyg Assoc J 43:897-889.
3. Avakian MD, Dellinger B, Fiedler H, Gullet B, Koshland C, Marklund S, Oberdörster G, Safe S, Sarofim A, Smith KR, Schwartz D, Suk WA. 2002. The origin, fate, and health effects of combustion by-products: A research framework. Environ Health Perspect 110(11):1155-1162.
4. Aymonier C, Schlotterbeck U, Antonietti L, Zacharias P, Thomann R, Tiller JC, Mecking S. 2002. Hybrids of silver nanoparticles with amphiphilic hyperbranched macromolecules exhibiting antimicrobial properties. Chem Commun 24:3018-3019.
5. Baker C, Pradhan A, Pakstis L, Pochan DJ, Shah SI. 2005. Synthesis and antibacterial properties of silver nanoparticles. J Nanosci Nanotechnol 5:244-249.
6. Bansal RC, Wang M-J, Donnet J-B. 1993. Carbon black: Science and technology. 2nd ed. New York: Marcel Dekker. 482 pp.
7. Bawden FC, Pirie NW. 1937. The isolation and some properties of liquid crystalline substances from Solanaceous plants infected with three strains of tobacco mosaic virus. Proceedings of the Royal Society of London, Series B, Biological Sciences, Vol. 832 (3 August 1937). pp 274-320.
8. Beaucage G, Rane S, Schaefer DW, Long G, Fischer D. 1999. Morphology of polyethylene-carbon black composites. J Polymer Sci: Part B: Polymer Phys 37:1105-1119.
9. Beijerinck MJ. 1898. Concerning a contagium vivum fluidum as cause of the spot disease of tobacco leaves. Verhandelingen der Koninkyke akademie Wettenschapppen te Amsterdam 65:3-21. [Phytopathological Classics Number 7, 1942. St Paul, Minnesota: American Phytopathological Society Press].
10. Bell DJ, Dong L, Nelson BJ, Golling M, Zhang L, Grutzmacher D. 2006. Fabrication and characterization of three-dimensional InGaAs/GaAs nanosprings. Nano Lett 6(4):725-729.
11. Bernstein DM, Chevalier J, Smith P. 2003a. Comparison of Calidria chrysotile asbestos to pure tremolite: Inhalation biopersistence and histopathology following short-term exposure. Inhal Toxicol 15(14):1387-1419.
12. Bernstein DM, Rogers R, Smith P. 2003b. The biopersistence of Canadian chrysotile asbestos following inhalation. Inhal Toxicol 15(13):1247-1274.
13. Berry JP, Arnoux B, Stanislas G, Galle P, Chretien J. 1977. A microanalytic study of particles transport across the alveoli: Role of blood platelets. Biomed 27:354-357.
14. Blackburn JL, Engtrakul C, McDonald TJ, Dillon AC, Heben MJ. 2006. Effects of surfactant and boron doping on the BWF feature in the Raman spectrum of single-wall carbon nanotube aqueous dispersions. J Phys Chem B Condens Matter Mater Surf Interfaces Biophys 110:25551-25558.
15. Biswas P, Wu C-Y. 2005. Nanoparticles and the environment. J Air Waste Manage Assoc 55:708-746.
16. Bodian D, Howe HA. 1941. Experimental studies on intraneural spread of poliomyelitis virus. In: Bordley JI, editor. Bulletin of the Johns Hopkins Hospital. Baltimore: The Johns Hopkins Press. pp 248-267.
17. Borm PA, Kreyling W. 2004. Toxicological hazards of inhaled nanoparticles - potential implication for drug delivery. J Nanosci Nanotechnol 4(5):521-531.
18. Brant J, Lecoanet H, Hotze M, Wiesner M. 2005. Comparison of electrokinetic properties of colloidal fullerenes (n-C60) formed using two procedures. Environ Sci Technol 39:6343-6351.
19. Brody AR, Warheit DB, Chang LY, Roe MW, George G, Hill LH. 1984. Initial deposition pattern of inhaled minerals and consequent pathogenic events at the alveolar level. Ann NY Acad Sci 428:108-120.
20. Brody AR, Hill LH,Warheit DB. 1985. Induction of early alveolar injury by inhaled asbestos and silica. Federation Proc 44:2596-2601.
21. Brown RC, Bellmann B, Muhle H, Davis JM, Maxim LD. 2005. Survey of the biological effects of refractory ceramic fibres: Overload and its possible consequences. Ann Occup Hyg 49(4):295-307.
22. Brown JS, Zeman KL, Bennett WD. 2002. Ultrafine particle deposition and clearance in the healthy and obstructed lung. Am J Respir Crit Care Med 166:1240-1247.
23. Brown DM, Wilson MR, MacNee W, Stone V, Donaldson K. 2001. Size-dependent proinflammatory effects of ultrafine polystyrene particles: A role for surface area and oxidative stress in the enhanced activity of ultrafines. Toxicol Appl Pharmacol 175:191-199.
24. Cedervall T, Lynch I, Lindman S, Tulin E, Nilsson H, Dawson KA, Linse S. 2007. Novel methods to quantify binding rates and affinities of proteins to nanoparticles: Effects of nanoparticle composition and size. PNAS 104:2050-2055.
25. Chen B-X, Wilson SR, Das M, Coughlin DJ, Erlanger BF. 1998. Antigenicity of fullerenes. Antibodies specific for fullerenes and their characteristics. PNAS USA 95:10809-10813.
26. Chen M, von Mikecz A. 2005. Formation of nucleoplasmic protein aggregates impairs nuclear function in response to SiO2 nanoparticles. Experim Cell Res 305(1):51-62.
27. Churg A, Green F. 1999. Pathology of occupational lung disease. 2nd ed. Baltimore: Williams and Wilkins.
28. 198Au from nasal mucous membrane into cerebrospinal fluid. Acta Otolaryng 70:58-61.
29. Colvin VL. 2003. The potential environmental impact of engineered nanomaterials. Nature Biotechnol 21:1166-1170.
30. Dalal NS, Jafari B, Petersen M, Green FY, Vallyathan V. 1991. Presence of stable coal radicals in autopsied coal-miners lungs and its possible correlation to coal-workers pneumoconiosis. Arch Environ Health 46:366-372.
31. Davis JM, Addison J, Bolton RE, Donaldson K, Jones AD, Smith T. 1986. The pathogenicity of long versus short fibre samples of amosite asbestos administered to rats by inhalation and intraperitoneal injection. Br J Exp Pathol 67(3):415-430.
32. Davis JM, Brown DM, Cullen RT, Donaldson K, Jones A, Miller A, McIntosh BG, Searl A. 1996. A comparison of methods for determining and predicting the pathogenicity of mineral fibres. Inhal Toxicol 8:747-770.
33. DeLorenzo A. 1970. The olfactory neuron and the blood-brain barrier. In: Wolstenholme G, Knight J, editors. Taste and smell in vertebrates. London: J. & A. Churchill. p 151-176.
34. Derfus AM, Chan WCW, Bhatia SN. 2004. Probing the cytotoxicity of semiconductor quantum dots. Nano Letters 4(1):11-18.
35. Donaldson K, Golyasnya N. 2004. Cytogenetic and pathogenic effects of long and short amosite asbestos. J Pathol 177.
36. Donaldson K, Beswick PH, Gilmour PS. 1996. Free radical activity associated with the surface of particles: A unifying factor in determining biological activity? Toxicol Lett 88(1-3):293-298.
37. Donaldson K, Li XY, MacNee W. 1998. Ultrafine (nanometre) particle mediated lung injury. J Aerosol Sci 29(5/6):553-560.
38. Donaldson K, Brown D, Clouter A, Duffin R, MacNee W, Renwick L, Tran L, Stone V. 2002. The pulmonary toxicology of ultrafine particles. J Aerosol Med - Deposition Clearance & Effects in the Lung 15(2):213-220.
39. Donaldson K, Tran CL. 2004. An introduction to the short-term toxicology of respirable industrial fibres. Mutat Res 553(1-2):5-9.
40. Donaldson K, Stone V, Tran CL, Kreyling W, Borm PJ. 2004. Nanotoxicology 188. Occup Environ Med 61(9):727-728.
41. Donaldson K, Tran L, Jimenez LA, Duffin R, Newby DE, Miles N, MacNee W, Stone V. 2005. Combustion-derived nanoparticles: A review of their toxicology following inhalation exposure. Particle Fibre Toxicol 2(1):10 (on line; doi: 10.1186/1743-8977-2-10).
42. Donaldson K, Aitken R, Tran L, Stone V, Duffin R, Forest G, Alexander A. 2006. Carbon nanotubes: A review of their properties in relation to pulmonarytoxicology and workplace safety. Toxicological Sci 92(1):5-22.
43. Douglas T, Young M. 2006. Viruses: Making friends with old foes. Science 312:873-875.
44. Drinker P, Thomson RM, Finn JL. 1927a. Metal fume fever: II. Resistance acquired by inhalation of zinc oxide on two successive days. J Ind Hyg Tox 9(3):98-105.
45. Drinker P, Thomson RM, Finn JL. 1927b. Metal fume fever: IV. Threshold doses of zinc oxide preventive measures and the chronic effects of repeated exposures. J Ind Hyg Tox 9:331-345.
46. Ehrenberg M, McGrath JL. 2005. Binding between particles and proteins in extracts: Implications for microrheology and toxicity. Acta Biomaterialia 1:305-315.
47. Elder A, Gelein R, Silva V, Feikert T, Opanashuk L, Carter J, Potter R, Maynard A, Ito Y, Finkelstein J, Oberdörster G. 2006. Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ Health Perspect 114:1172-1178.
48. Elimelech M. 1994. Effect of particle size on the kinetics of particle deposition under attractive double layer interactions. J Colloid Interface Sci 164:190-199.
49. EPA. 2004. Air quality criteria for particulate matter (Vol. III) 600/P-95-001cF. Washington, DC 20460: Office of Research and Development.
50. Erlanger BF, Chen B-X, Zhu M, Brus L. 2005. Binding of an anti-fullerene IgG monoclonal antibody to single wall carbon nanotubes. Nano Lett 1(9):465-467.
51. European Commission. 2005. Research needs on nanoparticles. In: Tomellini R, de Villepin C, editors. Proceedings of workshop held in Brussels on 25-26 January 2005. (www.cordis.lu/nanotechnology). 96 pp.
52. Faux SP, Michelangeli F, Levy LS. 1994. Calcium chelator Quin-2 prevents crocidolite-induced DNA strand breakage in human white blood cells. Mutat Res 311(2):209-215.
53. Ferin J, Oberdörster G, Penney DP, Soderholm SC, Gelein R, Piper HC. 1990. Increased pulmonary toxicity of ultrafine particles? I. Particle clearance, translocation, morphology. J Aerosol Sci 21:381-384.
54. Fiorito S, Serafino A, Andreola F, Bernier P. 2006. Effects of fullerenes and single-wall carbon nanotubes on murine and human macrophages. Carbon 44(6):1100-1105.
55. 60 in water: nanocrystal formation and microbial response. Environ Sci Technol 39:4307-4316.
56. Fujishima A, Honda K. 1972. Electrochemical photolysis of water at a semiconductor electrode. Nature 238:37-38.
57. Furno F, Morley KS, Wong B, Sharp BL, Arnold PL, Howdle SM, Bayston R, Brown PD, Winship PD, Reid HJ. 2004. Silver nanoparticles and polymeric medical devices: A new approach to prevention of infection? J Antimicrob Chemother 54:1019-1024.
58. Gabor S, Anca Z. 1975. Effect of asbestos on lipid peroxidation in the red cells. Br J Ind Med 32(1):39-41.
59. Gardner LU. 1938. Experimental Pneumoconiosis. In: Lanza AJ, editor. Silicosis and asbestosis. New York: Oxford University Press.
60. Geiser M, Rothen-Rutishauser B, Kapp N, Schurch S, Kreyling W, Schulz H, Semmler M, Im Hof V, Heyder J, Gehr P. 2005. Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ Health Perspect 113:1555-1560.
61. Gharbi N, Pressac M, Hadchouel M, Szwarc H, Wilson SR, Moussa F. 2005. 60]fullerene is a powerful antioxidant in vivo with no acute or subacute toxicity. Nano Lett 5(12):2578-2585.
62. Gilmour PS, Brown DM, Lindsay TG, Beswick PH, MacNee W, Donaldson K. 1996. Adverse health-effects of PM(10) Particles - involvement of iron in generation of hydroxyl radical. Occupat Environ Med 53:817-822.
63. Gilmour PS, Brown DM, Beswick PH, MacNee W, Rahman I, Donaldson K. 1997. Free radical activity of industrial fibers: Role of iron in oxidative stress and activation of transcription factors. Environ Health Perspect 105:1313-1317.
64. Gopinath PG, Gopinath G, Kumar A. 1978. Target site of intranasally sprayed substances and their transport across the nasal mucosa: A new insight into the intranasal route of drug delivery. Curr Therapeutic Res 23(5):596-607.
65. Gordon T, Chen LC, Fine JM, Schlesinger RB, Su WY, Kimmel TA, Amdur MO. 1992. Pulmonary effects of inhaled zinc oxide in human subjects, guinea pigs, rats, and rabbits. Am Ind Hyg Assoc J 53(8):503-509.
66. Gulyaev AE, Gelperina SE, Skidan IN, Antropov AS, Kivman GY, Kreuter J. 1999. Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles. Pharm Res 16:1564-1569.
67. Heckel K, Kiefmann R, Dorger M, Stoeckelhuber M, Goetz AE. 2004. Colloidal gold particles as a new in vivo marker of early acute lung injury. Am J Physiol Lung Cell Mol Physiol 287:L867-878.
68. Hoet PHM, Bruske-Hohlfeld I, Salata OV. 2004. Nanoparticles - known and unknown health risks. J Nanobiotechnol 2(12):12-27.
69. Hoshino A, Fujioka K, Oku T, Suga M, Sasaki YF, Ohta T, Yasuhara M, Suzuki K., Yamamoto K. 2004. Physicochemical properties and cellular toxicity of nanocrystal quantum dots depend on their surface modification. Nano Lett 4(11):2163-2169.
70. Howe HA, Bodian D. 1940. Portals of entry of poliomyelitis virus in the chimpanzee. Proc Soc Exp Biol Med 43:718-721.
71. Huang L, Li DQ, Lin YJ, Wei M, Evans DG, Duan X. 2005. Controllable preparation of Nano-MgO and investigation of its bactericidal properties. J Inorg Biochem 99:986-993.
72. IARC. 2006. Baan R, Straif K, Grosse Y, et al. on behalf of the WHO International Agency for Research on Cancer Monograph Working Group. Carcingenicity of carbon black; titanium dioxide, and talc. The Lancet 7:295-296.
73. International Commission on Radiological Protection (ICRP). 1994. Annals of the ICRP: Human respiratory tract model for radiological protection. Smith H, editor. ICRP Publication 66. Vol. 24, Nos. 1-3, Oxford, UK: Pergamon.
74. International Commission on Radiological Protection (ICRP). 1966. Deposition and retention models for internal dosimetry of the human respiratory tract. Task Group on Lung Dynamics. Health Phys 12:173-208.
75. International Life Sciences Institute (ILSI). 2005. Oberdörster et al. and a report from the ILSI Research Foundation/Risk Science Institute Nanomaterial Toxicity Screening Working Group. Principles for characterizing the potential human health effects from exposure to nanomaterials: Elements of a screening strategy. Particle Fibre Toxicol 2005(2):8.
76. Ito A, Kuga Y, Honda H, Kikkawa H, Horiuchi A, Watanabe Y, Kobayashi T. 2004. Magnetite nanoparticle-loaded anti-HER2 immunoliposomes for combination of antibody therapy with hyperthermia. Cancer Lett 212:167-175.
77. Jackson BP, Ranville JF, Bertsch PM, Sowder AG. 2005. Characterization of colloidal and humic-bound Ni and U in the "dissolved" fraction of contaminated sediment extracts. Environ Sci Technol 39:2478-2485.
78. Janssen YM, Barchowsky A, Treadwell M, Driscoll KE, Mossman BT. 1995. Asbestos induces nuclear factor kappa B (NF-kappa B) DNA-binding activity and NF-kappa B-dependent gene expression in tracheal epithelial cells. Proc Natl Acad Sci USA 92(18):8458-8462.
79. Jia G, Wang H, Yan L, Wang X, Pei R, Yan T, Zhao YL, Guo X. 2005. Cytotoxicity of carbon nanomaterials: Single-wall nanotube, multi-wall nanotube, and fullerene. Environ Sci Technol (in press).
80. Johnson NF. 1994. Phagosomal pH and glass fiber dissolution in cultured nasal epithelial cells and alveolar macrophages: a preliminary study. Environ. Health Perspectives 102(suppl. 5):97-102.
81. Jötten KW, Klosterkötter W. 1952. Die Bedeutung der Löslichkeit der Kieselsäure in der Lunge von Kaninchen. Arch Hyg 136:451-467.
82. Kagan VE, Tyurina YY, Tyurin VA, Konduru NV, Potapovich AI, Osipov AN, Kisin ER, Schwegler-Berry D, Mercer R, Castranova V, Shvedova AA. 2006. Direct and indirect effects of single walled carbon nanotubes on RAW 264.7 macrophages: Role of iron. Toxicol Lett 165(1):88-100.
83. Kanti ST, Khilar KC. 2006. Review on subsurface colloids and colloid-associated contaminant transport in saturated porous media. Adv Colloid Interface Sci 119:71-96.
84. Kato T, Yashiro T, Murata Y, Herbert DC, Oshikawwa K, Bando M, Ohno S, Sugiyama Y. 2003. Evidence that exogenous substances can be phagocytized by alveolar epithelial cells and transported into blood capillaries. Cell Tiss Res 311:47-51.
85. Katz LC, Burkhalter A, Dreyer WJ. 1984. Fluorescent latex microspheres as a retrograde neuronal marker for in vivo and in vitro studies of visual cortex. Nature 310:498-500.
86. Kausche GA, Pfankuch E, Ruska H. 1939. Die Sichtbarmachung von pflanzlichem Virus im Übermikroskop. Naturwissenschaften 27:292-299.
87. Kennedy T, Hopkins C, Dodson R, Rao NV, Tolley E, Hoidal J. 1988. Silica generates OH radicals and causes red-cell hemolysis by acting as a fenton reagent. Clin Res 36:A.
88. Kirchner C, Liedl T, Kudera S, Pellegrino T, Javier AM, Gaub HE, Stolzle S, Fertig N, Parak WJ. 2005. Cytotoxicity of colloidal CdSe and CdSe/ZnS nanoparticles. Nano Lett 5(2):331-338.
89. Konig MF, Lucocq JM, Weibel ER. 1993. Demonstration of pulmonary vascular perfusion by electron and light microscropy. J Appl Physiol 75(4):1877-1883.
90. Kreuter J. 2001. Nanoparticulate systems for brain delivery of drugs. Adv Drug Delivery Rev 47:65-81.
91. Kreyling W, Semmler M, Erbe, Mayer P, Takenaka S, Schulz H, Oberdörster G, Ziesenis A. 2003. Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J Toxicol Environ Health 65A(20):1513-1530.
92. Kreyling WG, Semmler M, Moller W. 2004. Dosimetry and toxicology of ultrafine particles. J Aerosol Med 17(2):140-152.
93. Lam CW, James JT, McCluskey R, Hunter RL. 2004. Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicological Sci 77:126-134.
94. Lam CW, James J, McCluskey R, Sivaram A, Hunter R. 2006. A review of carbon nanotube toxicity and assessment of potential occupational and environmental health risks. Crit Rev Toxicol 36(3):189-217.
95. Lead JR, Muirhead D, Gibson CT. 2005. Characterization of freshwater natural aquatic colloids by atomic force microscopy (AFM). Environ Sci Technol 39:6930-6936.
96. Lee S-H. 2005. Inactivation of bacterial endospores by photocatalytic nanocomposites. Colloid Surface 40:93-98.
97. Li N, Sioutas C, Cho A, Schmiz D, Misra C, Sempf J, Wang M, Oberley T, Froines JR, Nel A. 2003. Ultrafine particulate pollutants induce oxidative stress and mitochondrial damage. Environmental Health Perspectives 111(4):455-460.
98. Lisunova MO, Lebovka NI, Melezhyk OV, Boiko YP. 2006. Stability of the aqueous suspensions of nanotubes in the presence of nonionic surfactant. J Colloid Interface Sci 299:740-746.
99. 60) nanoparticles. Environ Toxicol Chem 25:1132-1137.
100. Lundborg M, Eklund A, Lind B, Camner P. 1985. Dissolution of metals by human and rabbit alveolar macrophages. Brit J Ind Med 42:642-645.
101. Malsch I, Oud M. 2004. Outcome of the Open Consultation on the European Strategy for Nanotechnology. December, 2004; www.nanoforum.org
102. Maynard AD, Baron PA, Foley M, Shvedova AA, Kisin ER, Castranova V. 2004. Exposure to carbon nanotube material: Aerosol release during the handling of unrefined single walled carbon nanotube material. J Toxicol Environ Health A67:87-107.
103. McCarthy JF, Yurek GJ, Elliott JF, Amdur MO. 1982. Generation and characterization of submicron aerosols of zinc oxide. Am Ind Hyg Assoc J 43:880-886.
104. McCarthy JF, Zachara JM. 1989. Subsurface transport of contaminants: mobile colloids in the subsurface environment may alter the transport of contaminants. Environ Sci Technol 23:496-502.
105. McConnell EE, Axten C, Hesterberg TW, Chevalier J, Miller WC, Everitt J, Oberdöster G, Chase GR, Thevenaz P, Kotin P. 1999. Studies on the inhalation toxicology of two Fiberglasses and Amosite Asbestos in the Syrian Golden Hamster. Part II. Results of chronic exposure 1. Inhal Toxicol 11(9):785-835.
106. Mehta D, Bhattacharya J, Matthay MA, Malik AB. 2004. Integrated control of lung fluid balance. Am J Physiol Lung Cell Mol Physiol 287:L1081-1090.
107. 2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J 12(5):2005-2015.
108. Mills A, Hunte SLJ. 1997. An overview of semiconductor photocatalysis. J Photochem Photobiol A: Chem 108:1-35.
109. Mills NL, Amin N, Robinson SD, Anand A, Davies J, Patel D, de la Fuente JM, Cassee FR, Boon NA, MacNee W, Millar AM, Donaldson K, Newby DE. 2006. Do inhaled carbon nanoparticles translocate directly into the circulation in humans? Am J Respir Crit Care Med 173:426-431.
110. Mossman B, Landesman J. 1983. Importance of oxygen free radicals in asbestos-induced injury to airway epithelial cells. CHEST 83:50S-51.
111. Mossman B, Marsh J, Shatos M. 1986. Alteration of superoxide dismutase activity in tracheal epithelialcells by asbestos and inhibition of cytotoxicity by antioxidants. Lab Invest 54:204-212.
112. Mossman BT, Marsh JP, Sesko A, Hill S, Shatos MA, Doherty J, Petruska J, Adler KB, Hemenway D,Mickey R, Vacek P, Kagan E. 1990. Inhibition of lung injury, inflammation, and interstitial pulmonary fibrosis by polyethylene glycol-conjugated catalase in a rapid inhalation model of asbestosis. Am Rev Respiratory Dis 141:1266-1271.
113. Müller RH, Keck CM. 2004. Drug delivery to the brain - realization by novel drug carriers. J Nanosci Nanotechnol 4:471-483.
114. Muller J, Huaux F, Moreau N, Misson P, Heilier J-F, Delos M, Arras M, Fonseca A, Nagy JB, Lison D. 2005. Respiratory toxicity of multi-all carbon nanotubes. Toxicol Appl Pharmacol 207:221-231.
115. National Nanotechnology Initiative (NNI). 2006. NNI: Environmental, Health and Safety Research Needs for Engineered Nanoscale Materials. NNI White paper issued by the Office of the President of the United States, September, 2006.
116. Nel A, Xia T, Mädler L, Li N. 2006. Toxic potential of materials at the nano level. Science 311(5761):622-627.
117. Nemmar A, Hoet PHM, Vanquickenborne B, et al. 2002. Passage of inhaled particles into the blood circulation in humans. Circulation 105:411-414.
118. Nemmar A, Hoylaerts MF, Hoet PHM, Nemery B. 2004. Possible mechanism of the cardiovascular effects of inhaled particles: Systemic translocation and prothrombotic effects. Toxicol Lett 149:243-253.
119. 60) induce oxidative stress in the brain of juvenile largemouth bass. Environ Health Perspect 112:1058-1062.
120. Oberdörster G, Hochrainer D, Ma RH. 1979. Zinc oxide aerosols: Generation, lung clearance and effects of lung clearance. Gesellschaft für Aerosolforschung 7:132-137.
121. Oberdörster G, Ferin J, Finkelstein J, Wade P, Corson N. 1990. Increased pulmonary toxicity of ultrafine particles? II. Lung lavage studies. J Aerosol Sci 21:384-387.
122. Oberdörster G, Ferin J, Gelein R, Soderholm SC, Finkelstein J. 1992. Role of the alveolar macrophage in lung injury: Studies with ultrafine particles. Environ Health Perspect 97:193-197.
123. Oberdörster G, Ferin J. 1992. Metal compounds used in new technologies: Metal oxides of ultrafine particles have increased pulmonary toxicity. In: Merian E, Haerdi W, editors. Metal compounds in environment & life. Vol. 4. Science & Technology Letters. Northwood, UK: Science Reviews. pp 443-450.
124. Oberdörster G, Gelein R, Ferin J, Weiss B. 1995. Association of particulate air pollution and acute mortality: Involvement of ultrafine particles? Inhalation Toxicol 7:111-124.
125. Oberdörster G, Sharp Z, Atudorei V, Elder A, Gelein R, Kreyling W, Cox C. 2004. Translocation of inhaled ultrafine particles to the brain. Inhalation Toxicol 16(6/7):437-445.
126. Oberdörster G, Oberdörster E, Oberdörster J. 2005. Invited review: Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113:823-839.
127. 60) on aquatic organisms. Carbon 44(6):1112-1120.
128. Panté N, Kann M. 2002. Nuclear pore complex is able to transport macromolecules with diameters of ∼39 nm. Molec Biol Cell 13:425-434.
129. Peters A, von Klot S, Heier M, Trentinaglia I, Hörmann A, Wichmann HE, Löwel H. 2004. Exposure to traffic and the onset of myocardial infarction. N Eng J Med 351:1721-1730.
130. Quinlan TR, Marsh JP, Janssen YW, Borm PA, Mossman BT. 1994. Oxygen radicals and asbestos-mediated disease. Environ Health Perspect 102:107-110.
131. Roco MC. 2003a. The future of the National Nanotechnology Initiative. (http://www.nano.gov/html/res/slides.pdf).
132. Roco MC. 2003b. Converging science and technology at the nanoscale: Opportunities for education and training. Nat Biotechnol 21:1247-1249.
133. Rouse JG, Yang J, Ryman-Rasmusen JP, Barrow AR, Monteior-Riviere NA. 2007. Effects of mechanical flexion on the penetration of fullerene amino acid-derivatized peptide nanoparticles through skin. NanoLetters 7(1):155-160.
134. Royal Society and Royal Academy of Engineers. 2004. Nanoscience and nanotechnologies: opportunities and uncertainties. 2004.
135. Rückerl R, Ibald-Mulli A, Koenig W, Schneider A, Woelke G, Cyrys J, Heinrich J, Marder V, Frampton M, Wichmann HE, Peters A. 2006. Air pollution and Markers of inflammation and coagulation in patients with coronary heart disease. Am J Respir Crit Care Med 173:432-441.
136. Ruska H, von Borries B, Ruska E. 1940. Die Bedeutung der Übermikroskopie für die Virusforschung. Arch Ges Virusforsch 1:155-169.
137. Ryman-Rasmussen JP, Riviere JE, Monteiro-Riviere NA. 2006. Penetration of intact skin by quantum dots with diverse physiochemical properties. Tox Sci 91:159-165.
138. Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR). 2005. http://files.nanobio-raise.org/Downloads/scenihr.pdf accessed 22/01/2007.
139. Sato Y, Yokoyama A, Shibata K, Akimoto Y, Ogino S, Nodasaka Y, Kohgo T, Tamura K, Akasaka T, Uo M, Motomiya K, Jeyadevan B, Ishiguro M, Hatakeyama R, Watari F, Tohji K. 2005. Influence of length on cytotoxicity of multi-walled carbon nanotubes against human acute monocytic leukemia cell line THP-1 in vitro and subcutaneous tissue of rats in vivo. Mol Biosyst 1(2):176-182.
140. Sayes CM, Fortner JD, Guo W, Lyon D, Boyd AM, Ausman KD, Tao YJ, Sithaaraman B, Wilson LJ, Hughes JB, West JL, Colvin VL. 2004. The differential cytotoxicity of water-soluble fullerenes. Nano Lett 4(10):1881-1887.
141. Sayes CM, Liang F, Hudson JL, Mendez J, Guo W, Beach JM, Moore VC, Doyle CD, West JL, Billups WE, Ausman KD. 2006. Functionalization density dependence of single-walled carbon nanotubes cytotoxicity in vitro. Toxicol Lett 161(2):135-142.
142. Schiller CF, Gebhart J, Heydeer J, Rudolf G, Stahlhofen W. 1986. Factors influencing total deposition of ultrafine aerosol particles in the human respiratory tract. J Aerosol Sci 17(3):328-332.
143. Schreck R, Albermann K, Baeuerle PA. 1992. Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radic Res Commun 17(4):221-237.
144. Seaton A, MacNee W, Donaldson K, Godden D. 1995. Particulate air pollution and acute health effects. Lancet 345(Jan. 21):176-178.
145. Selikoff IJ, Lee DHK. 1978. Asbestos and disease. New York: Academic Press.
146. Semmler M, Seitz J, Erbe F, Mayer P, Heyder J, Oberdörster G, Kreyling W. 2004. Long-term clearance kineic of inhaled ultrafine insoluble iridium particles from the rat lung, including transient translocation into secondary organs. Inhalation Toxicol 16(6/7):453-459.
147. Shen Z, Parker VD, Aust AE. 1995. Mediated, thin-layer cell, coulometric determination of redox-active iron on the surface of asbestos fibers. Anal Chem 67(2):307-311.
148. Shvedova AA, Kisin ER, Mercer R, Murray AR, Johnson VJ, Potapovich AI, Tyurina YY, Gorelik O, Arepalli S, Schwegler-Berry D, Hubbs AF, Antonini J, Evans DE, Ku BK, Ramsey D, Maynard A, Kagan VE, Castranova V, Baron P. 2005. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am J Physiol Lung Cell Mol Physiol 289(5):L698-708.
149. Silva VM, Corson N, Elder A, Oberdörster G. 2005. The rat ear vein model for investigating in vivo thrombogenicity of ultrafine particles (UFP). Toxicological Sci 85:983-989.
150. Smith AE, Helenius A. 2004. How viruses enter animal cells. Science 304:237-242.
151. Sondi I, Salopek-Sondi B. 2004. Silver nanoparticles as antimicrobial agent: A case study on E. coli as a model for Gram-negative bacteria. J Colloid Interface Sci 275:177-182.
152. Spadaro JA, Berger TJ, Barranco SD, Chapin SE, Becker RO. 1974. Antibacterial effects of silver electrodes with weak-direct current. Microb Agents Chemother 6:637-642.
153. Stanley WM. 1935. Isoltion of a crystalline protein assessing the properties of tobacco mosaic virus. Science 81(2113):644-645.
154. Stone V, Shaw J, Brown DM, MacNee W, Faux SP, Donaldson K. 1998. The role of oxidative stress in the prolonged inhibitory effect of ultrafine carbon black on epithelial cell function. Toxicol In Vitro 12:649-659.
155. Sunada K, Kikuchi Y, Hashimoto K, Fujishima A. 1998. Bactericidal and detoxification effects of TiO2 thin film photocatalysts. Environ Sci Technol 32:726-728.
156. Swift DL, Montassier N, Hopke PK, Karpen-Hayes K, Cheng YS, Su YF, Yeh HC, Strong JC. 1992. Inspiratory deposition of ultrafine particles in human nasal replicate cast. J Aerosol Sci 23:65-72.
157. Swift DL, Montassier N, Hopke PK, Karpen-Hayes K, Cheng YS, Su YF, Yeh HC, Strong JC. 1994. Inspiratory deposition of ultrafine particles in human nasal replicate cast. J Aerosol Sci 23:65-72.
158. Teague SV, Raabe OG. 1980. Generation of fume aerosols of zinc oxide. Am Ind Hyg Assoc J 41:680-683.
159. Timbrell V. 1982. Deposition and retention of fibres in the human lung. Ann Occup Hyg 26:347-369.
160. Tinkle SS, Antonini JM, Rich BA, Roberts JR, Salmen R, DePree K, Adkins EJ. 2003. Skin as a route of exposure and sensitization in chronic beryllium disease. Environ Health Perspect 111:1202-1208.
161. Tsoli M, Kuhn H, Brandau W, Esche H, Schmid G. 2005. Cellular uptake and toxicity of Au55 clusters. Small 1(8-9):841-844.
162. Vallyathan V, Dalal NS, Newman J, Pack D. 1993. Potential role of coal-mine dust in the generation of hydroxyl radicals - possible implication in coal-workers pneumoconiosis 690. Am Rev Respiratory Dis 147:A.
163. Vicent MJ, Duncan R. 2006. Polymer conjugates: Nanosized medicines for treating cancer. Trends Biotechnol 24:39-47.
164. Wagner JC, Skidmore JW, Hill RJ, Griffiths DM. 1985. Erionite exposure and mesotheliomas in rats. Br J Cancer 51(5):727-730.
165. Wang IC, Tai LA, Lee DD, Kanakamma PP, Shen CK, Luh TY, Cheng CH, Hwang KC. 1999. C(60) and water-soluble fullerene derivatives as antioxidants against radical-initiated lipid peroxidation. J Med Chem 42(22):4614-4620.
166. Wang ZL. 2004. Functional oxide nanobelts: Materials, properties and potential applications in nanosystems and biotechnology 4261. Annu Rev Phys Chem 55:159-196.
167. Warheit DB, Chang LY, Hill LH, Hook GR, Crapo JD, Brody AR. 1984. Pulmonary macrophage accumulation and asbestos-induced lesions at sites of fiber deposition. Am Rev Respiratory Dis 129:301-310.
168. Warheit DB, Laurence BR, Reed KL, Roach DH, Reynolds GAM, Webb TR. 2004. Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicological Sci 77:117-125.
169. Warheit DB, Webb TR, Sayes CM, Colvin VL, Reed KL. 2006. Pulmonary instillation studies with nanoscale TiO2 rods and dots in rats: Toxicity is not dependent upon particle size and surface area. Toxicol Sci 91(1):227-236.
170. Whitby KT, Clark WE, Marple VA, Sverdrup GM, Sem GJ, Willeke K, Liu BYH, Pui DYH. 1975. Characterization of California aerosols Size distribution of freeway aerosol. Atmospheric Environ 9:463-482.
171. Wilson MR, Donaldson K, Stone V. 2001. Oxidative interactions between ultrafine particles and metals. Am J Resp Crit Care Med 163(5):A495 p.
172. Yang L, Watts DJ. 2005. Particle surface characteristics may play an important role in phytotoxicity of alumina nanoparticles. Toxicol Lett 158:122-132.
173. Zhang W-S. 2003. Nanoscale iron particles for environmental remediation: An overview. J Nanopart Res 5:323-332.
174. Zhang Q, Kusaka Y, Sato K, Nakakuki K, Kohyama N, Donaldson K. 1998. Differences in the extent of inflammation caused by intratracheal exposure to three ultrafine metals: Role of free radicals. J Toxicol Environ Health 53(6):423-438.
175. Zhu S, Oberdörster E, Haasch ML. 2006. Toxicity of an engineered nanoparticle (fullerene, C(60)) in two aquatic species, Daphnia and fathead minnow. Mar Environ Res
176. Zhuang J, Qi J, Jin Y. 2005. Retention and transport of amphiphilic colloids under unsaturated flow conditions: Effect of particle size and surface property. Environ Sci Technol 39:7853-7859.